Prosidyan Gains CE Marks for Bone Graft Substitutes

Prosidyan has received CE mark certifications for its Fibergraft bone graft substitutes, which are designed for use in spinal fusion procedures.

The ultraporous synthetic technology uses proprietary nano- and micro-sized bioactive glass fibers to optimize resorption rates, provide direct connectivity and cover a large surface area.

The CE marks cover broad indications for the company’s Fibergraft BG Putty and BG Morsels product for fusion procedures in the lumbar and anterior cervical spine, the company said.